Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/23/1996 | EP0738324A1 Synergistic antifungal protein and compositions containing same |
10/23/1996 | EP0738323A1 Thrombopoietin |
10/23/1996 | EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof |
10/23/1996 | EP0738321A1 Association of kinesin with sensitivity to chemotherapeutic drugs |
10/23/1996 | EP0738320A1 Synthetic antimicrobial peptides |
10/23/1996 | EP0738283A1 New polyaminocarboxylate chelators |
10/23/1996 | EP0738281A1 Peptides and methods against psoriasis |
10/23/1996 | EP0738280A1 Superactive vip antagonists |
10/23/1996 | EP0738279A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
10/23/1996 | EP0738278A1 Expression of surface layer proteins |
10/23/1996 | EP0738277A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
10/23/1996 | EP0738276A1 Method for purification of a mixture of hydroxamate derivatized protein and native protein |
10/23/1996 | EP0738158A1 Biological targeting agents |
10/23/1996 | EP0738156A1 Methods and compositions for inhibiting thrombogenesis |
10/23/1996 | EP0738155A1 Modular design and synthesis of oxazolone-derived molecules |
10/23/1996 | EP0640143A4 Senescent cell derived inhibitors of dna synthesis. |
10/23/1996 | EP0629213B1 Use of an immunostimulatory agent |
10/23/1996 | EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides |
10/23/1996 | EP0528886B1 Beta cell antigen |
10/23/1996 | EP0431072B1 Recombinant fowlpox virus |
10/23/1996 | EP0422125B1 Platelet blocking peptides |
10/23/1996 | EP0416094B1 Parathyroid hypertensive factor |
10/23/1996 | EP0276262B1 Merozoite surface antigen of plasmodium falciparum |
10/23/1996 | CN1134175A Viral vector with bovine viral diarrhea virus (BVDV) antigens |
10/23/1996 | CN1134174A Modified plant viruses as vectors of heterologous peptides |
10/23/1996 | CN1134173A Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
10/23/1996 | CN1134172A Protocadherin proteins and their uses |
10/23/1996 | CN1134159A Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparation contg. these compounds |
10/23/1996 | CN1134158A N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions contg. these compounds |
10/23/1996 | CN1134157A Process for preparation of virus-inactivated factor VIII-contg. fraction by chromatographic methods |
10/23/1996 | CN1134154A Metal complexes with charged linker |
10/23/1996 | CN1134113A Method for inducing antigen-specific T cell tolerance |
10/23/1996 | CN1134111A Method of using insulin-like growth factor binding proteins |
10/23/1996 | CN1134110A Method for regulating gastrointestinal motility |
10/23/1996 | CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
10/23/1996 | CN1133887A Regulatory gene for expression of nitrile hydratase gene |
10/23/1996 | CN1133885A Preparation of alpha-1 antichymotrypsin |
10/22/1996 | US5567862 Synthetic insecticidal crystal protein gene |
10/22/1996 | US5567809 Methods and reagents for HLA DRbeta DNA typing |
10/22/1996 | US5567807 Using an anionic exchange resin |
10/22/1996 | US5567805 The cellular receptor for the CS3 peptide of human immunodeficiency virus |
10/22/1996 | US5567803 Anti-obesity proteins |
10/22/1996 | US5567681 PGLa and XPF peptides and uses therefor |
10/22/1996 | US5567678 Anti-obesity proteins |
10/22/1996 | US5567676 Bactericides |
10/22/1996 | US5567620 Non-denaturing potency assay for somatotropin |
10/22/1996 | US5567611 Multifunctional M-CSF proteins and genes encoding therefor |
10/22/1996 | US5567603 HIV-3 retrovirus and its use |
10/22/1996 | US5567600 Synthetic insecticidal crystal protein gene |
10/22/1996 | US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification |
10/22/1996 | US5567584 Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
10/22/1996 | US5567582 Dna sequences |
10/22/1996 | US5567408 YIGSR peptide radiopharmaceutical applications |
10/22/1996 | US5567295 Method and apparatus for making staggered blade edge connectors |
10/22/1996 | CA1338664C Recombinant hosts |
10/22/1996 | CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/17/1996 | WO1996032641A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals |
10/17/1996 | WO1996032502A1 Reagent specific for apolipoprotein-j polymorphisms and uses thereof |
10/17/1996 | WO1996032498A1 Phycobilisomes, derivatives, and uses therefor |
10/17/1996 | WO1996032494A1 Fusion protein delivery system and uses thereof |
10/17/1996 | WO1996032493A1 Hp-8 autoantigen |
10/17/1996 | WO1996032487A1 Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
10/17/1996 | WO1996032486A1 Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
10/17/1996 | WO1996032483A1 Immune-evading proteins |
10/17/1996 | WO1996032482A1 Bacteriocins |
10/17/1996 | WO1996032481A1 New chemokine expressed in eosinophils |
10/17/1996 | WO1996032480A2 METHODS AND COMPOSITIONS FOR DETERMINING HER-2/neu EXPRESSION |
10/17/1996 | WO1996032479A1 Hookworm vaccine |
10/17/1996 | WO1996032478A1 Altered polypeptides with increased half-life |
10/17/1996 | WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
10/17/1996 | WO1996032475A2 Methods for preparing dna-binding proteins |
10/17/1996 | WO1996032471A2 Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology |
10/17/1996 | WO1996032469A1 Method for producing a highly enriched population of osteoclast cells |
10/17/1996 | WO1996032468A2 Bioprocess for production of dipeptide based compounds |
10/17/1996 | WO1996032414A1 Glucagon-like peptide-2 and its therapeutic use |
10/17/1996 | WO1996032413A1 Process for the purification of glycoproteins like erythropoietin |
10/17/1996 | WO1996032412A1 PEPTIDE SUPPRESSING IxBα PHOSPHORYLATION |
10/17/1996 | WO1996032411A1 Binding sites for phosphotyrosine binding domains |
10/17/1996 | WO1996032407A1 Igf-i purification process |
10/17/1996 | WO1996032406A1 A simple method for the purification of a bioelastic polymer |
10/17/1996 | WO1996032137A2 Methods of inducing immune tolerance using immunotoxins |
10/17/1996 | WO1996032134A2 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
10/17/1996 | WO1996032133A2 Conjugate for treating inflammatory, infectious and/or skin diseases |
10/17/1996 | WO1996032132A1 Peptides of nematode tubulin and methods of use |
10/17/1996 | WO1996032129A1 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |
10/17/1996 | WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein |
10/17/1996 | WO1996032127A1 Methods of enhancing epithelial cell proliferation |
10/17/1996 | WO1996032126A1 Analogs of growth hormone-releasing factor |
10/17/1996 | WO1996032124A1 Modified lysine or arginine containing proteins and peptides |
10/17/1996 | WO1996032123A1 Pharmaceutical preparations derived from korean mistletoe |
10/17/1996 | WO1996032121A1 Pharmaceutical preparations derived from european mistletoe |
10/17/1996 | WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
10/17/1996 | WO1996032106A1 Aglyco products |
10/17/1996 | WO1996032087A2 Transgenic fish in the treatment of diabetes |
10/17/1996 | WO1996032007A1 Transgenic tomato plants containing a fusarium resitance gene |
10/17/1996 | WO1996023066A3 Prostaglandin receptor, dp |
10/17/1996 | WO1996022375A3 Procedures and materials for conferring disease resistance in plants |
10/17/1996 | WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
10/17/1996 | WO1996022308A3 Appetite suppression factor and related methods |
10/17/1996 | WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |